Researchers in the lab of Michael Mitchell in Penn Engineering have developed a method for delivering lipid nanoparticles across the blood-brain barrier specifically to targeted neurons.
To respond to the generational public health crisis caused by the global COVID-19 pandemic, a swift, coordinated effort across many sectors of society is necessary, say National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., and Johnson & Johnson Vice Chairman of the Executive Committee and Chief Scientific Officer Paul Stoffels, M.D.
We are pleased to share that the Health and Human Services (HHS) team at the National Institutes of Health (NIH) has been awarded the Technology Transfer Innovation Award by the Federal Laboratory Consortium, “New Enterprise Technology Transfer System Revolutionizes Tech Transfer at NIH”.
The National Cancer Institute (NCI) has awarded a five-year grant to researchers at Winship Cancer Institute of Emory University who are developing nanoparticles to treat pancreatic cancer, one of the most deadly cancers.